Purple Biotech Ltd
PPBT
$2.60
-$0.05-1.89%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 8.25% | -1.61% | |
| Total Depreciation and Amortization | -- | -- | -1.99% | -6.13% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -134.94% | -40.16% | |
| Change in Net Operating Assets | -- | -- | -91.58% | -72.32% | |
| Cash from Operations | -- | -- | -19.06% | -17.72% | |
| Capital Expenditure | -- | -- | 88.46% | 88.46% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -12.57% | 49.16% | |
| Cash from Investing | -- | -- | -30.30% | 28.47% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -1.82% | -1.21% | |
| Issuance of Common Stock | -- | -- | 4.34% | -6.98% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 1,951.14% | -38.16% | |
| Cash from Financing | -- | -- | 389.14% | -14.10% | |
| Foreign Exchange rate Adjustments | -- | -- | 135.29% | 136.03% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -113.07% | 105.93% | |